Boards of directors
Management
Ulrika Warpman Berglund
CEO, Member of the Board
Håkan Nordlander
Head of administration and accounting
Austin Smith
Chief Medical Officer
Monika Vedin
Business strategy & Communication Director
Christina Kaldéren
Preclinical Director
Emil Lindmark
Legal Counsel
Auditor
Ernst & Young has been the Company’s auditor since 2014.
At the 2023 Annual General Meeting, the accounting firm was reelected to be the company’s auditor. Andreas Nyberg was appointed as lead auditor. The accounting firm and the main responsible auditor Andreas Nyberg do not perform any services that could bring their independent into question.
EY’s office address is Box 7850, 103 99 Stockholm.
Nomination committee
The Nomination Committeé shall consist of representatives of the largest shareholders in Oxcia AB as of 30 September. The Nomination Committee for the 2023 Annual General Meeting consists of Kristina Edfeldt (appointed by the Thomas Helleday Foundation for Medical Research), Thomas Helleday (appointed by Thomas Helleday) and Mats Persson (appointed by Martin Scobie). The chairman is Kristina Edfeldt.
The Nomination Committee’s task is to prepare and present proposals for the number of board members to be elected by the meeting, the election of chairman and other members of the board, board fees, election of chairman at the Annual General Meeting, election of auditors (if applicable) and auditor fees and proposed rules for the appointment of a nomination committeé for the next Annual General Meeting.
Shareholders can leave suggestions to the Nomination Committee by e-mailing the suggestion to info@oxcia.com, please put “Till Oxcias valberedning” in the subject line.
Articles of association April 2022
Other
Oxcia’s general meeting was held on the 13th of June 2023. Minutes and other documents can be found here.